The Value of Geriatric Assessments in Older Patients With Breast Cancer
The Value of Geriatric Assessments in Predicting Treatment Tolerance and Overall Survival in Older Patients With Breast Cancer.
Sponsor: Peking University People's Hospital
A observational or N/A phase clinical study on Aging and Breast Cancer, this trial is ongoing. The trial is conducted by Peking University People's Hospital and has accumulated 6 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Jun 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Jun 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2021 — Jul 2024 [monthly]
Recruiting
-
Jun 2019 — Jan 2021 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
▶ Show 1 earlier version
-
Sep 2018 — Jun 2019 [monthly]
Active Not Recruiting
First recorded
Apr 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .